Performant Healthcare, Inc. (PHLT)
NASDAQ: PHLT · Real-Time Price · USD
7.64
+4.09 (115.21%)
At close: Aug 1, 2025, 4:00 PM
7.57
-0.07 (-0.92%)
After-hours: Aug 1, 2025, 7:58 PM EDT

Company Description

Performant Healthcare, Inc. provides audit, recovery, and analytics services in the United States.

It supports healthcare payers in identifying, preventing, and recovering waste and improper payments through advanced technology, analytics, and proprietary data assets.

The company also offers coordination-of-benefits services, as well as claims-based services, which includes the audit and identification of improperly paid claims.

Further, it provides advanced reporting capabilities, support services, customer care, and stakeholder training programs to mitigate future instances of improper payments.

The company was formerly known as Performant Financial Corporation and changed its name to Performant Healthcare, Inc. in December 2024.

Performant Healthcare, Inc. was founded in 1976 and is headquartered in Plantation, Florida.

Performant Healthcare, Inc.
Performant Healthcare logo
CountryUnited States
Founded1976
IndustryHealth Information Services
SectorHealthcare
Employees964
CEOSimeon Kohl

Contact Details

Address:
900 South Pine Island Road, Suite 150
Plantation, Florida 33324
United States
Phone925 960 4800
Websiteperformantcorp.com

Stock Details

Ticker SymbolPHLT
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0001550695
CUSIP Number71377E105
ISIN NumberUS71377E1055
Employer ID20-0484934
SIC Code7380

Key Executives

NamePosition
Simeon M. KohlChief Executive Officer and Director
Lisa C. ImExecutive Chairman and Secretary
Rohit RamchandaniChief Financial Officer
Jon BozzutoHead of Investor Relations
Scott PutnamVice President of Sales
Melissa ChristChief People Officer
Amanda PurvisSenior Vice President of Product Innovation
Christian BassSenior Vice President of Payment Integrity
Michael FeidSenior Vice President of Eligibility and Recovery
Dr. Marlene Mullen-ClaytonChief Medical Director

Latest SEC Filings

DateTypeTitle
Aug 1, 20258-KCurrent Report
Aug 1, 20258-KCurrent Report
Jul 29, 2025SCHEDULE 13GFiling
Jun 23, 20258-KCurrent Report
Jun 9, 2025SCHEDULE 13D/AFiling
Jun 3, 2025144Filing
May 9, 202510-QQuarterly Report
May 8, 20258-KCurrent Report
Apr 28, 2025DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 24, 2025DEF 14AOther definitive proxy statements